欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IS/H/0270/004
药品名称Lenalidomid Alvogen
活性成分
    • lenalidomide 10.0 mg
剂型Capsule, hard
上市许可持有人Alvogen Malta Operations (ROW) Ltd., Malta Life Sciences Park, Building 1, Level 4, Sir Temi Zammit Buildings, San Gwann SGN 3000, Malta
参考成员国 - 产品名称Iceland (IS)
Lenalidomid Zentiva
互认成员国 - 产品名称
    • Hungary (HU)
      LENALIDOMIDE ZENTIVA 10 mg kemény kapszula
    • Latvia (LV)
      Lenalidomide Alvogen 10 mg cietās kapsulas
    • Lithuania (LT)
      Lenalidomide Alvogen 10 mg kietosios kapsulės
    • Bulgaria (BG)
      Lenalidomide Zentiva
    • Romania (RO)
    • Slovakia (SK)
      Lenalidomid Alvogen 10 mg tvrdé kapsuly
    • Croatia (HR)
      Lenalidomid Alvogen 10 mg tvrde kapsule
许可日期2018/04/16
最近更新日期2024/08/22
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase